Frontal lobe volume in patients with Huntington's disease - PubMed (original) (raw)
Frontal lobe volume in patients with Huntington's disease
E H Aylward et al. Neurology. 1998 Jan.
Abstract
Neuropathologic and neuroimaging studies have suggested that frontal lobes are affected in Huntington's disease (HD), and that atrophy in this region may be associated with some of the cognitive impairment and clinical decline observed in patients with HD. We measured gray and white matter volumes within the frontal lobes on MRI for 20 patients with HD (10 mildly affected and 10 moderately affected) and 20 age- and sex-matched control subjects. We also correlated frontal lobe measurements with measures of symptom severity and cognitive function. Patients who were mildly affected had frontal lobe volumes (both gray and white matter) essentially identical to those of control subjects, despite clearly abnormal basal ganglia. Patients who were moderately affected demonstrated significant reductions in total frontal lobe volume (17%) and frontal white matter volume (28%). Frontal lobe white matter volume reductions, but not total frontal lobe volume reductions, were disproportionately greater than overall brain volume reductions (17%). Frontal lobe volume correlated with symptom severity and general cognitive function, but these correlations did not remain significant after taking into account total brain volume. We conclude that cognitive impairment and symptom severity are associated with frontal lobe atrophy, but this association is not specific to the frontal lobes. Frontal lobe atrophy (like total brain atrophy) occurs in later stages of increasing HD symptom severity and this atrophy primarily involves white matter.
Similar articles
- Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
Rosas HD, Tuch DS, Hevelone ND, Zaleta AK, Vangel M, Hersch SM, Salat DH. Rosas HD, et al. Mov Disord. 2006 Sep;21(9):1317-25. doi: 10.1002/mds.20979. Mov Disord. 2006. PMID: 16755582 - Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research.
Bartzokis G, Beckson M, Lu PH, Edwards N, Rapoport R, Wiseman E, Bridge P. Bartzokis G, et al. Psychiatry Res. 2000 Apr 10;98(2):93-102. doi: 10.1016/s0925-4927(99)00052-9. Psychiatry Res. 2000. PMID: 10762735 - Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study.
Tsuruya K, Yoshida H, Haruyama N, Fujisaki K, Hirakata H, Kitazono T. Tsuruya K, et al. PLoS One. 2015 Dec 3;10(12):e0143706. doi: 10.1371/journal.pone.0143706. eCollection 2015. PLoS One. 2015. PMID: 26632813 Free PMC article. - Clinical, imaging, lesion, and genetic approaches toward a model of cognitive control.
Casey BJ, Tottenham N, Fossella J. Casey BJ, et al. Dev Psychobiol. 2002 Apr;40(3):237-54. doi: 10.1002/dev.10030. Dev Psychobiol. 2002. PMID: 11891636 Review.
Cited by
- Corticostriatal Dysfunction in Huntington's Disease: The Basics.
Bunner KD, Rebec GV. Bunner KD, et al. Front Hum Neurosci. 2016 Jun 28;10:317. doi: 10.3389/fnhum.2016.00317. eCollection 2016. Front Hum Neurosci. 2016. PMID: 27445757 Free PMC article. Review. - Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.
Hsu YY, Du AT, Schuff N, Weiner MW. Hsu YY, et al. J Geriatr Psychiatry Neurol. 2001 Fall;14(3):145-66. doi: 10.1177/089198870101400308. J Geriatr Psychiatry Neurol. 2001. PMID: 11563438 Free PMC article. Review. - "Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness.
Duff K, Paulsen JS, Beglinger LJ, Langbehn DR, Wang C, Stout JC, Ross CA, Aylward E, Carlozzi NE, Queller S; Predict-HD Investigators of the Huntington Study Group. Duff K, et al. J Neuropsychiatry Clin Neurosci. 2010 Spring;22(2):196-207. doi: 10.1176/jnp.2010.22.2.196. J Neuropsychiatry Clin Neurosci. 2010. PMID: 20463114 Free PMC article. - Robust Markers and Sample Sizes for Multicenter Trials of Huntington Disease.
Wijeratne PA, Johnson EB, Eshaghi A, Aksman L, Gregory S, Johnson HJ, Poudel GR, Mohan A, Sampaio C, Georgiou-Karistianis N, Paulsen JS, Tabrizi SJ, Scahill RI; IMAGE-HD, PREDICT-HD, and TRACK-HD investigators; Alexander DC. Wijeratne PA, et al. Ann Neurol. 2020 May;87(5):751-762. doi: 10.1002/ana.25709. Epub 2020 Mar 14. Ann Neurol. 2020. PMID: 32105364 Free PMC article. - Investigating longitudinal changes to frontal cortico-striatal tracts in Huntington's disease: the IMAGE-HD study.
Tan B, Shishegar R, Oldham S, Fornito A, Poudel G, Georgiou-Karistianis N. Tan B, et al. Brain Imaging Behav. 2022 Dec;16(6):2457-2466. doi: 10.1007/s11682-022-00699-6. Epub 2022 Jun 29. Brain Imaging Behav. 2022. PMID: 35768755 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical